臨床婦人科産科68巻11号

2014年11月発行

今月の臨床 妊娠高血圧症候群のベストマネジメント

診断と評価

5．胎児発育状態とwell-beingの評価

著者： 中本收¹

所属機関： ¹大阪市立総合医療センター産科

ページ範囲：P.1072 - P.1081

文献概要

●妊娠高血圧症候群，とりわけ妊娠高血圧腎症では，胎盤形成不全（子宮らせん動脈remodeling不全）によるFGR発症リスクがある．

●胎児心拍監視，母体子宮動脈血流，臍帯動脈・胎児中大脳動脈・動脈管血流計測やbiophysical profile，胎児発育度の定期的監視が求められるが，early-onset FGRの予後改善の最大要因は妊娠の継続であり，母体の妊娠高血圧症候群病態の重症度と併せて適切な分娩時期の選択が必要となる．

参考文献

1） Baschat AA : Fetal growth restriction-from observation to intervention. J Perinat Med 38 : 239─246, 2010

2） Pijnenborg R, et al : The uterine spiral arteries in human pregnancy : facts and controversies. Placenta 27 : 939─958, 2006

3） Lyall F, et al : Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction : relationship to clinical outcome. Hypertension 62 : 1046─1054, 2013

4） Redman CW, Sargent IL : Immunology of pre-eclampsia. Am J Reprod Immunol 63 : 534─543, 2010

5） Gramellini D, et al : Cerebral-umbilical Doppler ratio as a predictor of adverse perinatal outcome. Obstet Gynecol 79 : 416─420, 1992

6） Harrington K, et al : Doppler fetal circulation in pregnancies complicated by pre-eclampsia or delivery of a small for gestational age baby : 2. Longitudinal analysis. Br J Obstet Gynaecol 106 : 453─466, 1999

7） Odibo AO, et al : Cerebroplacntal Doppler ratio and adverse perinatal outcomes in intrauterine growth restriction. Evaluating the impact of using gestational age-specific reference values. JUM 24 : 1223─1228, 2005

8） Ahmad A, et al : Regulation of placental vascular endothelial growth factor（VEGF）and placenta growth factor（PIGF） and soluble Flt-1 by oxygen - a review. Placenta 21 : S16─24, 2000

9） De Vivo A, et al : Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. Acta Obstet Gynecol Scand 87 : 837─842, 2008

10） Gauster M, et al : Fusion of villous trophoblast can be visualized by localizing active caspase 8. Placenta 30 : 547─550, 2009

11） Mutter WP, et al : Molecular mechanisms of preeclampsia. Microvasc Res 75 : 1─8, 2008

12） Seval Y, et al : The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta. Placenta 29 : 809─815, 2008

13） Levine RJ, et al : Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol 194 : 1034─1041, 2006

14） Engels T, et al : Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders. Hypertens Pregnancy 32 : 459─473, 2013

15） DeLoiveira L, et al : sFlt-1/PlGF ratio as a prognostic marker of adverse outcomes in women with early-onset preeclampsia. Pregnancy Hypertension 3 : 191─195, 2013

16） Schneuer FJ, et al : First trimester screening of serum soluble fms-like tyrosine kinase-1 and placental growth factor predicting hypertensive disorders of pregnancy. Pregnancy Hypertension 3 : 215─221, 2013

17） Weiler J, et al : Is Fetal Growth Restriction Associated with a More Severe Maternal Phenotype in the Setting of Early Onset Pre-Eclampsia? A Retrospective Study. PLos One 6 : e26937, 2011

18） Kovo M, et al : Pregnancy Outcome and Placental Findings in Pregnancies Complicated by Fetal Growth Restriction With and Without Preeclampsia. Reprod Sci. 2014 6 : 1933719114542024.［Epub ahead of print］

19） Mitani M, et al : Clinical features of fetal growth restriction complicated later by preeclampsia. J Obstet Gynaecol Res 35 : 882─887, 2009

20） Tranquilli AL, et al : The classification, diagnosis and management of the hypertensive disorders of pregnancy : A revised statement from the ISSHP. Pregnancy Hypertension 4 : 97─104, 2014

21） Kiserud T, et al : Ductus venosus shunting in growth-restricted fetuses and the effect of umbilical circulatory compromise. Ultrasound Obstet Gynecol 28 : 143─149, 2006

22） Hofstaetter C, et al : Venous Doppler velocimetry in the surveillance of severely compromised fetuses. Ultrasound Obstet Gynecol 20 : 233─239, 2002

23） Kessler J, et al : Longitudinal study of umbilical and portal venous blood flow to the fetal liver : low pregnancy weight gain is associated with preferential supply to the fetal left liver lobe. Pediatr Res 63 : 315─320, 2008

24） Kessler J, et al : Fetal growth restriction is associated with prioritization of umbilical blood flow to the left hepatic lobe at the expense of the right lobe. Pediatr Res 66 : 113─117, 2009

25） Galan HL, et al : Fetal hypertension and abnormal Doppler velocimetry in an ovine model of intrauterine growth restriction. Am J Obstet Gynecol 192 : 272─279, 2005

26） Morrow RJ, et al : Effect of placental embolization on the umbilical artery velocity waveform in fetal sheep. Am J Obstet Gynecol 161 : 1055─1060, 1989

27） Baschat AA, et al : The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol 18 : 571─577, 2001

28） Manning FA, et al : Fetal biophysical profile score. VI. Correlation with antepartum umbilical venous fetal pH. Am J Obstet Gynecol 169 : 755─763, 1993

29） Vintzileos AM, et al : Relationship between fetal biophysical activities and umbilical cord blood gas values. Am J Obstet Gynecol 165 : 707─713, 1991

30） Mifsud W, et al : Placental pathophysiology in early-onset and late-onset fetal growth restriction. Fetal Diagn Ther, 2014（DOI : 10.1159/000359969）

31） Baschat AA : Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol 37 : 501─514, 2011

32） Baschat AA, et al : Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 109 : 253─261, 2007

33） O’Dwyer V, et al : Defining the residual risk of adverse perinatal outcome in growth restricted fetuses with normal umbilical artery blood flow. Am J Obstet Gynecol 211 : 420, e1─5, 2014（doi:10.1016/j.ajog.2014.07.033）

34） Hecher K, et al : Potential for diagnosing imminent risk to appropriate- and small-for-gestational- age fetuses by Doppler sonographic examination of umbilical and cerebral arterial blood flow. Ultrasound Obstet Gynecol 2 : 266─271, 1992

35） Froen JF, et al : Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand 83 : 801─807, 2004

36） Baschat AA : Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol 37 : 501─514, 2011

37） Senat MV, et al : Longitudinal changes in the ductus venosus, cerebral transverse sinus and cardiotocogram in fetal growth restriction. Ultrasound Obstet Gynecol 16 : 19─24, 2000

38） Baschat AA, et al : The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol 18 : 571─577, 2001

39） Ferrazzi E, et al : Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol 19 : 140─146, 2002

40） Cosmi E, et al : Doppler, cardiotocography, and biophysical profile changes in growth-restricted fetuses. Obstet Gynecol 106 : 1240─1245, 2005

41） Savchev S, et al : Evaluation of an optimal gestational age cut-off for the definition of early- and late-onset fetal growth restriction. Fetal Diagn Ther 36 : 99─105, 2014

42） Turan OM, et al : Duration of persistent abnormal ductus venosus flow and its impact on perinatal outcome in fetal growth restriction. Ultrasound Obstet Gynecol 38 : 295─302, 2011

43） Crispi F, et al : Does pre-eclampsia influence fetal cardiovascular function in early-onset intrauterine growth restriction? Ultrasound Obstet Gynecol 34 : 660─665, 2009

44） Murata Y, et al : Fetal heart rate accelerations and late decelerations during the course of intrauterine death in chronically catheterized rhesus monkeys. Am J Obstet Gynecol 144 : 218─223, 1982（PMID : 7114133）